Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jul;9(7):682-683.
doi: 10.1016/S2213-2600(21)00171-5. Epub 2021 Apr 9.

Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19

Alvar Agusti  1 , Ferran Torres  2 , Rosa Faner  3
Affiliations
Comment

Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19

Alvar Agusti et al. Lancet Respir Med. 2021 Jul.

Erratum in

No abstract available

PubMed Disclaimer

Conflict of interest statement

AA and RF are the leading investigators of a multicentre, randomised clinical trial supported by AstraZeneca, which is currently exploring the effects of inhaled budesonide in hospitalised patients with COVID-19 pneumonia (NCT04355637).

Comment on

  • Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial.
    Ramakrishnan S, Nicolau DV Jr, Langford B, Mahdi M, Jeffers H, Mwasuku C, Krassowska K, Fox R, Binnian I, Glover V, Bright S, Butler C, Cane JL, Halner A, Matthews PC, Donnelly LE, Simpson JL, Baker JR, Fadai NT, Peterson S, Bengtsson T, Barnes PJ, Russell REK, Bafadhel M. Ramakrishnan S, et al. Lancet Respir Med. 2021 Jul;9(7):763-772. doi: 10.1016/S2213-2600(21)00160-0. Epub 2021 Apr 9. Lancet Respir Med. 2021. PMID: 33844996 Free PMC article. Clinical Trial.

References

    1. Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat Med. 2021;27:28–33. - PubMed
    1. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonar disease (GOLD) 2021. www.goldcopd.org
    1. Global strategy for asthma management and prevention (GINA) 2020 update. 2020. https://ginasthma.org/wp-content/uploads/2020/04/GINA-2020-full-report_-... - PubMed
    1. Halpin DMG, Faner R, Sibila O, Badia JR, Agusti A. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? Lancet Respir Med. 2020;8:436–438. - PMC - PubMed
    1. Schultze A, Walker AJ, MacKenna B, et al. Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform. Lancet Respir Med. 2020;8:1106–1120. - PMC - PubMed

Associated data